Strategies to enhance identification of hereditary breast cancer gene carriers.
作者信息
Reid Sonya, Spalluto Lucy B, Pal Tuya
机构信息
Division of Hematology/Oncology, Vanderbilt University Medical Center , Nashville, TN, USA.
Veterans Health Administration - Tennessee Valley Healthcare System Geriatric Research, Education and Clinical Center (GRECC) , Nashville, TN, USA.
出版信息
Expert Rev Mol Diagn. 2020 Sep;20(9):861-865. doi: 10.1080/14737159.2020.1816829. Epub 2020 Sep 11.
Abstract
摘要
相似文献
1
Strategies to enhance identification of hereditary breast cancer gene carriers.增强遗传性乳腺癌基因携带者识别的策略。
Expert Rev Mol Diagn. 2020 Sep;20(9):861-865. doi: 10.1080/14737159.2020.1816829. Epub 2020 Sep 11.
2
Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.遗传性乳腺癌基因检测的新进展和基因携带者中高危乳腺癌的实际管理。
Semin Oncol. 2020 Aug;47(4):182-186. doi: 10.1053/j.seminoncol.2020.05.008. Epub 2020 May 26.
3
Counseling the at risk patient in the BRCA1 and BRCA2 Era.在BRCA1和BRCA2基因时代对高危患者进行咨询。
Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. doi: 10.1016/s0889-8545(01)00004-3.
4
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.特立尼达和多巴哥乳腺癌女性及其家族的临床结构化和合作式基因检测方法。
Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4.
5
[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].[遗传性乳腺癌和卵巢癌——基因检测的指征、咨询及突变携带者的选择]
Ther Umsch. 2010 Jul;67(7):359-66. doi: 10.1024/0040-5930/a000064.
6
Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.BRCA 携带者的决策和伦理问题及应用胚胎植入前遗传学诊断。
Minerva Med. 2009 Oct;100(5):371-83.
7
Double heterozygosity for and in breast cancer: considerations in surveillance and cancer risk management.乳腺癌中[具体基因]和[具体基因]的双重杂合性：监测与癌症风险管理的考量
BMJ Case Rep. 2025 Apr 22;18(4):e263687. doi: 10.1136/bcr-2024-263687.
8
Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?制定关于乳腺癌易感性基因检测的国家指南：经济证据的作用？
Genet Test Mol Biomarkers. 2012 Jun;16(6):580-91. doi: 10.1089/gtmb.2011.0236. Epub 2012 Feb 7.
9
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.重新访视那些先前使用12基因检测 panel检测BRCA突变呈阴性的乳腺癌患者。
Breast Cancer Res Treat. 2017 Jan;161(1):135-142. doi: 10.1007/s10549-016-4038-y. Epub 2016 Oct 31.
10
A new paradigm of genetic testing for hereditary breast/ovarian cancers.遗传性乳腺癌/卵巢癌基因检测的新范式。
Hong Kong Med J. 2016 Apr;22(2):171-7. doi: 10.12809/hkmj154634. Epub 2016 Mar 14.
本文引用的文献
1
A Web-Based Tool to Automate Portions of Pretest Genetic Counseling for Inherited Cancer.一个基于网络的工具，用于自动化遗传性癌症先证者遗传咨询的部分内容。
J Natl Compr Canc Netw. 2020 Jul;18(7):841-847. doi: 10.6004/jnccn.2020.7546.
2
Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.女性 BRCA1/2、PALB2、CHEK2 和 ATM 携带者的癌症风险管理。
Breast Cancer Res Treat. 2020 Jul;182(2):421-428. doi: 10.1007/s10549-020-05699-y. Epub 2020 May 22.
3
Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.绝经后乳腺癌女性中癌症易感性基因的致病性变异的流行率。
JAMA. 2020 Mar 10;323(10):995-997. doi: 10.1001/jama.2020.0229.
4
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.基于医院的乳腺癌女性队列的种系遗传检测标准评估。
J Clin Oncol. 2020 May 1;38(13):1409-1418. doi: 10.1200/JCO.19.02190. Epub 2020 Mar 3.
5
Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.遗传性基因检测结果与乳腺癌患者局部区域和全身治疗的相关性。
JAMA Oncol. 2020 Apr 1;6(4):e196400. doi: 10.1001/jamaoncol.2019.6400. Epub 2020 Apr 9.
6
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).需要考虑的要点：是否有证据支持对所有乳腺癌患者进行BRCA1/2及其他遗传性乳腺癌基因检测？美国医学遗传学与基因组学学会（ACMG）声明。
Genet Med. 2020 Apr;22(4):681-685. doi: 10.1038/s41436-019-0712-x. Epub 2019 Dec 13.
7
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测：美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
8
Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers.疑似遗传性乳腺癌和卵巢癌患者在基因检测和遗传咨询利用方面的障碍。
Proc (Bayl Univ Med Cent). 2019 Jun 11;32(3):340-344. doi: 10.1080/08998280.2019.1612702. eCollection 2019 Jul.
9
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.美国乳腺外科学会关于遗传性乳腺癌基因检测的共识指南。
Ann Surg Oncol. 2019 Oct;26(10):3025-3031. doi: 10.1245/s10434-019-07549-8. Epub 2019 Jul 24.
10
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.基于人群的乳腺癌患者和卵巢癌患者队列中的基因检测和结果。
J Clin Oncol. 2019 May 20;37(15):1305-1315. doi: 10.1200/JCO.18.01854. Epub 2019 Apr 9.
Zotero 插件